Swissmedic, the Swiss Agency for Therapeutic Products, has received 63 notifications of adverse effects following COVID vaccination, including six deaths, Report informs referring to the website of the Swiss government.
As of Feb. 4, 2021, a total of 63 reports of suspected adverse drug reactions in connection with the COVID vaccinations in Switzerland have been evaluated and assessed at Swissmedic, reads the message.
Of those patients affected, there were more women (57 percent) than men (32 percent), although the gender is not stated in some reports (11 percent).
Some 37 reports (59 percent) were classified as not serious. The most commonly reported reactions in these non-serious reports were headache, chills, fever and pain at the injection site.
Besides, 26 reports (41 percent) were classified as serious. The most common were breathing difficulties (dyspnoea), skin swelling (angioedema), skin rashes associated with allergic reactions and severe flu symptoms, including high fever or badly aching limbs.
In six of the serious reports, fatalities were reported in patients aged between 85 and 92 with pre-existing illnesses.